Literature DB >> 27283404

Osteoanabolic therapy for reduction of refracture risk after vertebral augmentation procedures? Response to Massarotti et al.

D Beall1, K Krohn2.   

Abstract

Mesh：

Substances：

Year:  2016        PMID： 27283404     DOI： 10.1007/s00198-016-3657-9

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN： 0937-941X            Impact factor:   4.507


× No keyword cloud information.
  2 in total

1.  Osteoanabolic therapy: a valid option to reduce refracture risk after vertebral augmentation procedures?

Authors:  M Massarotti; G Fabbriciani; M Barbieri; M De Santis; M Bukhari
Journal:  Osteoporos Int       Date:  2016-06-14       Impact factor: 4.507

2.  Patients with prior vertebral or hip fractures treated with teriparatide in the Direct Assessment of Nonvertebral Fractures in Community Experience (DANCE) observational study.

Authors:  D P Beall; R G Feldman; M L Gordon; B L Gruber; J M Lane; G Valenzuela; D Yim; J Alam; J H Krege; K Krohn
Journal:  Osteoporos Int       Date:  2015-11-10       Impact factor: 4.507
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.